We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-0.67%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$17.5B
AUM Growth
+$1.25B
(+7.7%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
15.74%
Holding
691
New
246
Increased
140
Reduced
132
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$274M |
| 2 |
Apple
AAPL
|
+$233M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$200M |
| 4 |
Jabil
JBL
|
+$185M |
| 5 |
Zoom
ZM
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$269M |
| 2 |
Oracle
ORCL
|
+$215M |
| 3 |
Estee Lauder
EL
|
+$172M |
| 4 |
Dell
DELL
|
+$160M |
| 5 |
Microsoft
MSFT
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.54% |
| 2 | Consumer Discretionary | 14.14% |
| 3 | Healthcare | 13.6% |
| 4 | Industrials | 12.07% |
| 5 | Financials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
F5
FFIV
$22.7B
| $9.6M | 0.05% |
+55,713
| New | +$9.74M |
|
277
Sarepta Therapeutics
SRPT
$1.77B
| $9.48M | 0.05% |
+60,000
| New | +$7.71M |
|
|
CIVI
278
DELISTED
Civitas Resources
CIVI
| $9.31M | 0.05% |
134,858
+56,817
| +73% | +$4.11M |
|
279
lululemon athletica
LULU
$14.6B
| $9.26M | 0.05% |
+31,013
| New | +$10.4M |
|
|
P
280
Everpure Inc
P
$29.9B
| $9.25M | 0.05% |
+143,989
| New | +$8.33M |
|
|
APLT
281
DELISTED
Applied Therapeutics
APLT
| $9.18M | 0.05% |
1,965,646
+522,720
| +36% | +$2.47M |
|
282
Murphy Oil
MUR
$4.78B
| $9.16M | 0.05% |
222,123
-30,332
| -12% | -$1.32M |
|
|
ABX
283
Abacus Global Management
ABX
$913M
| $9.08M | 0.05% |
+1,050,000
| New | +$11.8M |
|
284
Perion Network
PERI
$386M
| $9.07M | 0.05% |
+1,086,281
| New | +$13.2M |
|
285
PACS Group
PACS
$7.67B
| $9.07M | 0.05% |
+307,344
| New | +$8.37M |
|
286
Copart
CPRT
$27.5B
| $9.03M | 0.05% |
+166,670
| New | +$9.1M |
|
287
Westlake Corp
WLK
$9.9B
| $9M | 0.05% |
62,145
-44,606
| -42% | -$6.85M |
|
288
Las Vegas Sands
LVS
$29.6B
| $8.74M | 0.05% |
197,446
-517,848
| -72% | -$24.2M |
|
|
OKLO
289
Oklo
OKLO
$8.42B
| $8.56M | 0.05% |
+1,010,350
| New | +$11.4M |
|
290
Gentex
GNTX
$5.07B
| $8.47M | 0.05% |
251,245
-450,466
| -64% | -$15.6M |
|
291
Janux Therapeutics
JANX
$967M
| $8.35M | 0.05% |
199,384
+6,338
| +3% | +$298K |
|
292
Ascendis Pharma A/S
ASND
$16.8B
| $8.18M | 0.05% |
+60,000
| New | +$8.16M |
|
293
Unity
U
$18.9B
| $8.13M | 0.05% |
500,000
+265,865
| +114% | +$5.69M |
|
294
Kite Realty
KRG
$5.36B
| $8.03M | 0.05% |
358,697
-252,735
| -41% | -$5.38M |
|
295
Lincoln Educational Services
LINC
$1.3B
| $8.02M | 0.05% |
676,025
-55,265
| -8% | -$603K |
|
296
Parker-Hannifin
PH
$135B
| $7.77M | 0.04% |
15,356
-243,068
| -94% | -$130M |
|
|
INFN
297
DELISTED
Infinera Corporation Common Stock
INFN
| $7.73M | 0.04% |
+1,269,508
| New | +$6.72M |
|
298
Crescent Energy
CRGY
$3.82B
| $7.57M | 0.04% |
+638,485
| New | +$7.51M |
|
299
Cintas
CTAS
$81.3B
| $7.56M | 0.04% |
+43,208
| New | +$7.38M |
|
|
KBDC
300
Kayne Anderson BDC
KBDC
$937M
| $7.56M | 0.04% |
+473,989
| New | +$7.68M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2024 Portfolio in Review
As of Q2 2024, Alyeska Investment Group held 691 positions worth $17.5B, up 7.7% from $16.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Alyeska Investment Group deployed $1.35B of net new capital in Q2 2024, opening 246 new positions and adding to 140 existing holdings. Its largest new stake was Qualcomm: 1,450,565 shares worth $289M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Oracle, an estimated $215M trimmed.
- Alyeska Investment Group's largest Q2 2024 buy was Qualcomm: 1,450,565 shares worth $289M.
- Alyeska Investment Group added most to Zoom in Q2 2024, an estimated $163M increase.
- Alyeska Investment Group's biggest Q2 2024 reduction was Oracle, cutting an estimated $215M.
- Alyeska Investment Group fully exited Alphabet (Google) Class A in Q2 2024, selling an estimated $269M.
- Alyeska Investment Group's ten largest holdings make up 16% of its $17.5B portfolio in Q2 2024.
- Alyeska Investment Group opened 246 new positions and closed 135 in Q2 2024.
- Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $17.5B.
Based on Alyeska Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.